Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.

Human Genetics
Prakasha KempaiahDouglas J Perkins

Abstract

Severe malarial anemia (SMA) is a leading cause of pediatric morbidity and mortality in holoendemic Plasmodium falciparum transmission areas. Although dysregulation in cytokine production is an important etiology of SMA, the role of IFN-α in SMA has not been reported. As such, we investigated the relationship between IFN-α promoter polymorphisms [i.e., IFNA2 (A-173T) and IFNA8 (T-884A)], SMA, and functional changes in IFN-α production in children (n = 663; <36 months) residing in a holoendemic P. falciparum transmission region of Kenya. Children with SMA had lower circulating IFN-α than malaria-infected children without severe anemia (P = 0.025). Multivariate logistic regression analyses revealed that heterozygosity at -884 (TA) was associated with an increased risk of SMA [OR 2.80 (95 % CI 1.22-6.43); P = 0.015] and reduced IFN-α relative to wild type (TT; P = 0.038). Additional analyses demonstrated that carriage of the -173T/-884A (TA) haplotype was associated with increased susceptibility to SMA [OR 3.98 (95 % CI 1.17-13.52); P = 0.026] and lower IFN-α (P = 0.031). Follow-up of these children for 36 months revealed that carriers of TA haplotype had greater all-cause mortality than non-carriers (P < 0.001). Generation of rep...Continue Reading

References

Aug 1, 1978·Virology·E A HavellJ Vilcek
Apr 1, 1995·Protein Science : a Publication of the Protein Society·M H SetoE Croze
Nov 1, 1993·The Journal of Experimental Medicine·V BrinkmannC H Heusser
Dec 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·G R FosterH C Thomas
Apr 1, 1997·British Journal of Haematology·J A KurtzhalsL Hviid
Nov 14, 1997·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M W BeilharzC M Lawson
Dec 5, 1998·The American Journal of Tropical Medicine and Hygiene·C O ObonyoJ D Habbema
Jun 17, 2000·Infection and Immunity·A J LutyP G Kremsner
Jul 19, 2000·Current Opinion in Immunology·C Bogdan
Aug 16, 2000·Baillière's Best Practice & Research. Clinical Haematology·S N Wickramasinghe, S H Abdalla
Feb 13, 2001·The Journal of Nutrition·B J BrabinD Pelletier
Oct 5, 2001·Clinical Microbiology Reviews·C E Samuel
Apr 20, 2002·Lancet·Michael AidooVenkatachalam Udhayakumar
Jul 20, 2002·Methods in Molecular Medicine·Nicholas M AnsteyJocelyn R Saunders
Sep 10, 2003·Journal of Leukocyte Biology·Alexander IzaguirrePatricia Fitzgerald-Bocarsly
Dec 29, 2004·Growth Factors·Joseph BekiszKathryn C Zoon
Jul 8, 2005·American Journal of Human Genetics·Dominic P Kwiatkowski
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana Margarida VigárioLaurent Rénia
May 26, 2007·Biotechnology and Applied Biochemistry·Julio César Sánchez GarcíaVladimir Besada Perez
Dec 25, 2008·Annual Review of Immunology·Fernando O MartinezSiamon Gordon
Jan 13, 2009·East African Medical Journal·T MuasyaF A Okoth
Jun 17, 2009·Infection and Immunity·Christopher C KellerDouglas J Perkins
Apr 23, 2010·British Journal of Haematology·Enrico M NovelliDouglas J Perkins
Nov 26, 2010·Journal of Clinical Microbiology·T WereD J Perkins

❮ Previous
Next ❯

Citations

Jan 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jian WuXin-zhuan Su
Aug 21, 2014·The Journal of Infectious Diseases·Elizabeth B BrickleyPatrick E Duffy
Jun 30, 2015·Parasite Immunology·C G MatarA M Moormann
Mar 20, 2019·Frontiers in Immunology·Xi Zen YapMeredith O'Keeffe
Dec 22, 2020·Frontiers in Cellular and Infection Microbiology·Xiao HeXin-Zhuan Su

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.